Matrix metalloproteinase-2 is involved in myelination of dorsal root ganglia neurons

GLIA

Volumn 57, Issue 5, 2009, Pages 479-489

  Lehmann, Helmar C ^a   Köhne, Angelika ^a   Bernal, Fabian ^a   Jangouk, Parastoo ^a   Hörste, Gerd Meyer Zu ^a   Dehmel, Thomas ^a   Hartung, Hans Peter ^a   Previtali, Stefano C ^b   Kieseier, Bernd C ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Guillain Barr syndrome; Immune mediated neuropathy; Inflammation; Peripheral nerve; Regeneration; Schwann cell

Indexed keywords

COLLAGENASE 3; EDETIC ACID; GELATINASE A; GELATINASE B; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE INHIBITOR; MYELIN; CYTOKINE; MESSENGER RNA; MMP2 PROTEIN, HUMAN; MMP2 PROTEIN, RAT;

ADULT; AGED; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MYELINATION; NERVE BIOPSY; NERVE CELL CULTURE; NEUROPHYSIOLOGY; NEWBORN; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SCHWANN CELL; SPINAL GANGLION; SURAL NERVE; ZYMOGRAPHY; ANIMAL; CELL CULTURE; CEREBROSPINAL FLUID; ELECTRON MICROSCOPY; GENE EXPRESSION; METABOLISM; MYELIN SHEATH; MYELINATED NERVE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; POLYRADICULONEUROPATHY; ULTRASTRUCTURE;

ANIMALS; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; GANGLIA, SPINAL; GENE EXPRESSION; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 2; MICROSCOPY, ELECTRON; MYELIN SHEATH; NERVE FIBERS, MYELINATED; POLYMERASE CHAIN REACTION; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; RATS; RNA, MESSENGER; SCHWANN CELLS; SURAL NERVE;

EID: 65549167522     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20774     Document Type: Article

References (37)

1. Bernal F, Hartung H-P, Kieseier B. 2005. Tissue mRNA expression in rat of newly described matrix metalloproteinases. Biol Res 38:267-271.
2. Brockes JP, Fields KL, Raff MC. 1979. Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve Brain Res 165:105-118.
3. Bunge MB, Williams AK, Wood PM, Uitto J, Jeffrey JJ. 1980. Comparison of nerve cell and nerve cell plus Schwann cell cultures, with particular emphasis on basal lamina and collagen formation. J Cell Biol 84:184-202.
4. Carey DJ, Bunge RP. 1981. Factors influencing the release of proteins by cultured Schwann cells. J Cell Biol 91:666-672.
5. Carey DJ, Eldridge CF, Cornbrooks CJ, Timpl R, Bunge RP. 1983. Biosynthesis of type IV collagen by cultured rat Schwann cells. J Cell Biol 97:473-479.
6. Chandler S, Miller KM, Clements JM, Lury J, Corkill D, Anthony DC, Adams SE, Gearing AJ. 1997. Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: An overview. J Neuroimmunol 72:155-161.
7. Cornbrooks CJ, Carey DJ, McDonald JA, Timpl R, Bunge RP. 1983. In vivo and in vitro observations on laminin production by Schwann cells. Proc Natl Acad Sci USA 80:3850-3854.
8. Demestre M, Wells GM, Miller KM, Smith KJ, Hughes RA, Gearing AJ, Gregson NA. 2004. Characterisation of matrix metalloproteinases and the effects of a broad-spectrum inhibitor (BB-1101) in peripheral nerve regeneration. Neuroscience 124:767-779.
9. Einheber S, Milner TA, Giancotti F, Salzer JL. 1993. Axonal regulation of Schwann cell integrin expression suggests a role for α 6 β 4 in myelination. J Cell Biol 123:1223-1236.
10. Eldridge CF, Bunge MB, Bunge RP. 1989. Differentiation of axon-related Schwann cells in vitro. II. Control of myelin formation by basal lamina. J Neurosci 9:625-638.
11. Eldridge CF, Bunge MB, Bunge RP, Wood PM. 1987. Differentiation of axon-related Schwann cells in vitro. I. Ascorbic acid regulates basal lamina assembly and myelin formation. J Cell Biol 105:1023-1034.
12. Ferguson TA, Muir D. 2000. MMP-2 and MMP-9 increase the neuritepromoting potential of schwann cell basal laminae and are upregulated in degenerated nerve. Mol Cell Neurosci 16:157-167.
13. Heine W, Conant K, Griffin JW, Hoke A. 2004. Transplanted neural stem cells promote axonal regeneration through chronically denervated peripheral nerves. Exp Neurol 189:231-240.
14. Hughes RA, Cornblath DR. 2005. Guillain-Barre syndrome. Lancet 366:1653-1666.
15. Kieseier BC, Clements JM, Pischel HB, Wells GM, Miller K, Gearing AJ, Hartung HP. 1998a. Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barre syndrome. Ann Neurol 43:427-434.
16. Kieseier BC, Kiefer R, Clements JM, Miller K, Wells GM, Schweitzer T, Gearing AJ, Hartung HP. 1998b. Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis. Brain 121 (Part 1):159-166.
17. Kieseier BC, Schneider C, Clements JM, Gearing AJ, Gold R, Toyka KV, Hartung HP. 2001. Expression of specific matrix metalloproteinases in inflammatory myopathies. Brain 124:341-351.
18. Kieseier BC, Seifert T, Giovannoni G, Hartung HP. 1999. Matrix metalloproteinases in inflammatory demyelination: Targets for treatment. Neurology 53:20-25.
19. Koller H, Kieseier BC, Jander S, Hartung HP. 2005. Chronic inflammatory demyelinating neuropathy. N Engl J Med 352:1343-1356.
20. Krekoski CA, Neubauer D, Graham JB, Muir D. 2002. Metalloproteinase-dependent predegeneration in vitro enhances axonal regeneration within acellular peripheral nerve grafts. J Neurosci 22:10408-10415.
21. La Fleur M, Underwood JL, Rappolee DA, Werb Z. 1996. Basement membrane and repair of injury to peripheral nerve: Defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1. J Exp Med 184:2311-2326.
22. Larsen PH, DaSilva AG, Conant K, Yong VW. 2006. Myelin formation during development of the CNS is delayed in matrix metalloproteinase-9 and -12 null mice. J Neurosci 26:2207-2214.
23. Larsen PH, Yong VW. 2004. The expression of matrix metalloproteinase-12 by oligodendrocytes regulates their maturation and morphological differentiation. J Neurosci 24:7597-7603.
24. Lehmann HC, Köhne A, Meyer zu Hörste G, Dehmel T, Kiehl O, Hartung HP, Kastenbauer S, Kieseier BC. 2007. Role of nitric oxide as mediator of nerve injury in inflammatory neuropathies. J Neuropathol Exp Neurol 66:305-312.
25. Leppert D, Hughes P, Huber S, Erne B, Grygar C, Said G, Miller KM, Steck AJ, Probst A, Fuhr P. 1999. Matrix metalloproteinase upregulation in chronic inflammatory demyelinating polyneuropathy and nonsystemic vasculitic neuropathy. Neurology 53:62-70.
26. Milward E, Kim KJ, Szklarczyk A, Nguyen T, Melli G, Nayak M, Deshpande D, Fitzsimmons C, Hoke A, Kerr D, Griffin JW, Calabresi PA, Conant K. 2008. Cleavage of myelin-associated glycoprotein by matrix metalloproteinases. J Neuroimmunol 193:140-148.
27. Muir D. 1995. Differences in proliferation and invasion by normal, transformed and NF1 Schwann cell cultures are influenced by matrix metalloproteinase expression. Clin Exp Metastasis 13:303-314.
28. Pastrana E, Moreno-Flores MT, Gurzov EN, Avila J, Wandosell F, Diaz-Nido J. 2006. Genes associated with adult axon regeneration promoted by olfactory ensheathing cells: A new role for matrix metalloproteinase 2. J Neurosci 26:5347-5359.
29. Podratz JL, Rodriguez E, Windebank AJ. 2001. Role of the extracellular matrix in myelination of the peripheral nerve. Glia 25:35-40.
30. Renaud S, Erne B, Fuhr P, Said G, Lacroix C, Steck AJ, Leppert D. 2003. Matrix metalloproteinases-9 and -2 in secondary vasculitic neuropathies. Acta Neuropathol (Berl) 105:37-42.
31. Renaud S, Leppert D. 2007. Matrix metalloproteinases in neuromuscular disease. Muscle Nerve 36:1-13.
32. Saperstein DS, Katz JS, Amato AA, Barohn RJ. 2001. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 24:311-324.
33. Tian L, Stefanidakis M, Ning L, Van Lint P, Nyman-Huttunen H, Libert C, Itohara S, Mishina M, Rauvala H, Gahmberg CG. 2007. Activation of NMDA receptors promotes dendritic spine development through MMP-mediated ICAM-5 cleavage. J Cell Biol 178:687-700.
34. Vaillant C, Meissirel C, Mutin M, Belin MF, Lund LR, Thomasset N. 2003. MMP-9 deficiency affects axonal outgrowth, migration, and apoptosis in the developing cerebellum. Mol Cell Neurosci 24:395-408.
35. Werner SR, Mescher AL, Neff AW, King MW, Chaturvedi S, Duffin KL, Harty MW, Smith RC. 2007. Neural MMP-28 expression precedes myelination during development and peripheral nerve repair. Dev Dyn 236:2852-2864.
36. Yong VW. 2005. Metalloproteinases: Mediators of pathology and regeneration in the CNS. Nat Rev Neurosci 6:931-944.
37. Yong VW, Power C, Forsyth P, Edwards DR. 2001. Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2:502-511.